Hepatitis C patients on maintenance hemodialysis show complex immune disturbances in the peripheral blood

Masaaki Shiina1, Koju Kobayashi, Kazumasa Hiroishi

  • 11 Department of Gastroenterology and Hepatology, Shin-Yurigaoka General Hospital , Kawasaki, Japan .

Viral Immunology
|September 12, 2013
PubMed

Insights

Hepatitis C virus (HCV) infection impairs innate immunity in hemodialysis patients. Chronic HCV affects natural killer cells and monocytes, independent of hemodialysis, impacting patient survival.

Area of Science:

  • Immunology
  • Virology
  • Nephrology

Background:

  • Hepatitis C virus (HCV) infection is common in hemodialysis (HD) patients, affecting survival.
  • Both HCV and HD are associated with impaired innate immunity.
  • Antiviral treatment options for HCV in HD patients are limited.

Purpose of the Study:

  • To compare peripheral immunologic features in patients with maintenance hemodialysis and/or HCV infection.
  • To investigate the impact of chronic HCV infection on innate immunity in the context of hemodialysis.

Main Methods:

  • Analysis of peripheral blood mononuclear cells (PBMCs) from 30 subjects in four groups (HD, HCV, HD+HCV, controls).
  • Flow cytometry to analyze Natural Killer (NK) cell subsets and activation status (CD69 expression).
  • Cytokine production (Interferon-gamma, Tumor Necrosis Factor-alpha) measured via culture supernatant and single-cell analysis.

Main Results:

  • HCV-infected HD patients showed a decreased CD56(dim) NK cell subset but upregulated CD69 expression.
  • NK cells from both HCV-infected and uninfected HD patients exhibited poor response to LPS-induced Interferon-gamma and Tumor Necrosis Factor-alpha.
  • Tumor Necrosis Factor-alpha-producing monocytes were increased in HCV-infected HD patients compared to uninfected HD patients.

Conclusions:

  • Chronic HCV infection independently affects innate immunity, irrespective of hemodialysis.
  • Specific alterations in NK cell subsets and monocyte cytokine production are linked to HCV infection in HD patients.
  • Findings highlight the complex interplay between HCV, innate immunity, and hemodialysis.

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...